Potential role for mammalian target of rapamycin inhibitors as first-line therapy in hormone receptor–positive advanced breast cancer
J Thaddeus Beck Highlands Oncology Group, Fayetteville, AR, USA Abstract: Despite advances in cytotoxic chemotherapy and targeted therapies, 5-year ­survival rates remain low for patients with advanced breast cancer at diagnosis. This highlights the limited effectiveness of current treatme...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-12-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/potential-role-for-mammalian-target-of-rapamycin-inhibitors-as-first-l-peer-reviewed-article-OTT |